SAGA fluctuates 44.9% in 24 hours: trading volume surges over 7 times and open interest rises, driving a rebound
Bitget Pulse2026/05/11 20:51Volatility Overview
In the past 24 hours, the price of SAGA rebounded from a low of $0.0196 to a high of $0.0284, currently reported at $0.0268, with a fluctuation amplitude of 44.9%. Trading volume surged significantly, with CoinGecko data showing volumes between $96.26M and $153M, up 585.4%-703.4% from the previous day; CoinMarketCap reports $167M. There is no clear data on net capital inflow, but open interest (OI) increased concurrently by 15.5%.
Analysis of Abnormal Movements
- Both trading volume and open interest soared: Within 24 hours, trading volume reached 7.77 times the daily average level (about $50M-$106M), and OI rose by 15.5%, directly driving the price to rebound rapidly from the $0.017-$0.0186 lows to above $0.026.
- There were no official announcements, on-chain large transfers, or whale-related events recorded to verify, so the volatility is mainly amplified by market leverage trading.
Market Views and Outlook
The prevailing market sentiment leans towards a short-term rebound, with discussions on the X platform focusing on OI and trading volume metrics, regarding them as signals of "consolidation and buildup, increased volatility," but emphasizing that low liquidity (OI only $1.26M) could easily cause slippage. Analysts warn to watch support near $0.019, which, if broken, could lead to further corrections; the community is optimistic about a potential move towards $0.028, but overall forecasts are divided, with high short-term volatility expected to continue.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, and is for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
Crypto prices
More
